NASDAQ:MGNX

Macrogenics Stock Predictions

etoro logo Buy MGNX
*Your capital is at risk
$4.05
-0.0900 (-2.17%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

MGNX Prediction Chart

MGNX Predictions History

Latest community submissions for MGNX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 10, 2025 $1.80 +2.75% $1.69 X 93.60% 0
Oct 10, 2025 $1.72 -1.72% $1.69 V 98.23% 1
Oct 10, 2025 Bullish $1.69 X 0
Dec 26, 2024 $3.18 -2.61% $3.26 X 97.39% 0
Dec 26, 2024 $3.21 -1.63% $3.26 X 98.37% 0
Dec 3, 2024 $3.58 -2.91% $3.44 V 95.85% 1
Dec 3, 2024 $3.62 -1.82% $3.44 V 94.68% 1
Dec 3, 2024 $3.90 +5.69% $3.44 X 86.63% 0
Dec 2, 2024 $3.48 -3.00% $3.69 X 94.37% 0
Dec 2, 2024 $3.52 -1.88% $3.69 X 95.47% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MGNX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MACROGENICS
MacroGenics
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE